Novo Nordisk Aktie
WKN: 866931 / ISIN: US6701002056
|
05.11.2025 16:00:00
|
Prediction: Novo Nordisk Will Soar by 2026
Novo Nordisk (NYSE: NVO) has dropped over 50%, but its expanding GLP-1 pipeline and bold $5.2 billion acquisition could drive the next phase of explosive growth. With analysts turning bullish, investors might be looking at one of 2025's biggest comeback stories.Stock prices used were the market prices of Oct. 28, 2025. The video was published on Nov. 3, 2025.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novo Nordiskmehr Nachrichten
Analysen zu Novo Nordiskmehr Analysen
| 07:50 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07:44 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 07:23 | Novo Nordisk Outperform | Bernstein Research | |
| 06.11.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 06.11.25 | Novo Nordisk Buy | Deutsche Bank AG |
Aktien in diesem Artikel
| Novo Nordisk | 39,18 | -2,31% |
|
| Novo Nordisk (spons. ADRs) | 39,20 | -2,49% |
|